AzTrials
AzTrials

Syncope, VasovagalPhase 2NCT00302900

Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations

A Phase 2 study testing Pre-Donation Water Consumption, Muscle Tensing Exercise During Donation and Muscle Tensing Exercise Prior to Donation in people with Syncope, Vasovagal, run by Ohio University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many individuals experience negative reactions when donating blood, including dizziness, lightheadedness, or fainting. Such reactions may discourage them from donating again. This study will evaluate the effectiveness of pre-donation water consumption and a muscle tensing exercise during donation to reduce negative… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Syncope, Vasovagal
What is being tested?
Pre-Donation Water Consumption, Muscle Tensing Exercise During Donation and Muscle Tensing Exercise Prior to Donation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
441 participants
Where
2 sitesUnited States
Study dates
Jan 2006to Mar 2010
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Must meet American Red Cross donor eligibility requirements

Who cannot join

  • No more than two prior blood donations

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Ohio University

    Athens, Ohio, 45701

  • American Red Cross Blood Services - Central Ohio Region

    Columbus, Ohio, 43205

Other trials in United States

About this study

Official title: Preventing Adverse Reactions in Novice Blood Donors

Many individuals experience negative reactions when donating blood, including dizziness, lightheadedness, or fainting. Such reactions may discourage them from donating again. This study will evaluate the effectiveness of pre-donation water consumption and a muscle tensing exercise during donation to reduce negative reactions among new blood donors. This study will also evaluate whether reducing negative reactions increases the likelihood of donors returning to give blood in the future.

Read the detailed description

Severe and potentially dangerous shortages in the blood supply are increasingly common in the United States. As the population ages and as more stringent donor eligibility restrictions are enforced, blood shortages are expected to worsen. One way to meet the increasing demand for blood is to recruit new blood donors. Ideally, these individuals would become lifelong donors, and contribute up to six times per year and up to hundreds of units of blood within a lifetime. Unfortunately, less than half of all new donors provide a second donation. Many individuals who donate blood experience dizziness, weakness, lightheadedness, or in severe cases, fainting. As a result of these negative reactions, many individuals never donate blood again. Preventing these reactions may be an effective way to encourage subsequent blood donations. The purpose of this study is to evaluate the effectiveness of consuming water prior to donation and performing a muscle tensing exercise during donation as ways to reduce negative reactions in new blood donors. The study's long-term goal is to provide blood collection agencies with simple and inexpensive strategies to prevent negative reactions and enhance donor retention.

This study will enroll American Red Cross blood donors who have donated blood no more than twice previously. Participants will be randomly assigned to one of the following four groups: 1) pre-donation water consumption and muscle tensing exercise during donation; 2) pre-donation water consumption; 3) pre-donation muscle tensing exercise; or 4) no treatment. Participant reactions will be assessed at the time of donation by self-report and phlebotomist ratings, as well as by self-report 24 hours following the donation. Participants' subsequent donation history will be tracked for two years by reviewing the American Red Cross national donor database.

Being tested
Pre-Donation Water Consumption, Muscle Tensing Exercise During Donation, Muscle Tensing Exercise Prior to Donation
Keywords
Blood Donation, Syncope, Vasovagal Reactions
Medical subject headings
Syncope, Vasovagal, Syncope

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pre-Donation Water ConsumptionBehavioural

    Consumption of 500 ml of bottled water 30 minutes prior to donating

  • Muscle Tensing Exercise During DonationBehavioural

    Alternating leg lifts at 10-second intervals during donation

  • Muscle Tensing Exercise Prior to DonationBehavioural

    Alternating leg lifts at 10-second intervals prior to insertion of the donation needle

Study groups in NCT00302900
Study groupRoleWhat they receive
1ExperimentalPre-donation water and muscle tension during donation
Receives: Behavioral: Pre-Donation Water Consumption; Behavioral: Muscle Tensing Exercise During Donation
2ExperimentalPre-donation water
Receives: Behavioral: Pre-Donation Water Consumption
3Sham comparatorPre-donation muscle tension
Receives: Behavioral: Muscle Tensing Exercise Prior to Donation
4No interventionStandard donation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participant ratings of negative (vasovagal) reactions

    Measured: Measured within 30 minutes of donating

  2. Phlebotomist ratings of donor reactions

    Measured: Measured immediately following donation

  3. Number of repeat donations

    Measured: Measured 2 years post-donation

Secondary outcomes (2)
  1. Subjective ratings of muscle soreness and fatigue

    Measured: Measured 24 hours post-donation

  2. Negative (vasovagal) reactions

    Measured: Measured 24 hours post-donation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2006 (estimated)
  2. Study startJan 2006
  3. Primary completionMar 2010
  4. Study completionMar 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
441 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00302900
Sponsor's protocol ID
371
Other IDs
R01HL077438
Status last verified
Feb 2009
First submitted
14 Mar 2006
Last updated
6 Oct 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: Deidentified data is available upon request from the primary investigator.

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Pre-Donation Water Consumption, Muscle Tensing Exercise During Donation and Muscle Tensing Exercise Prior to Donation in people with Syncope, Vasovagal, run by Ohio University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participant ratings of negative (vasovagal) reactions (time frame: Measured within 30 minutes of donating). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in